Search results
Results from the WOW.Com Content Network
The primary method to treat transfusion-dependent anemia is by transfusing packed red blood cells. [9] Transfusion is also one of the treatment strategies for beta-thalassemia patients and patients with myelodysplastic syndrome (MDS). [13] Although transfusion of red blood cells cannot correct the underlying problems, it can improve anemia ...
Thrombocytopenia – a deficiency of platelets; Pancytopenia – when all three types of blood cells; red blood cells, white blood cells, and platelets, are all deficient. This is a life-threatening disorder that is a characteristic of aplastic anemia. [3] There are also two general causes of cytopenia: autoimmune and refractory.
However, the use of bleeding time in diagnosis is discouraged by the American Society of Hematology practice guidelines [15] and a normal bleeding time does not exclude a platelet disorder. [16] Bone marrow examination may be performed on patients over the age of 60 and those who do not respond to treatment, or when the diagnosis is in doubt. [12]
Due to the high mortality of untreated TTP, a presumptive diagnosis of TTP is made even when only microangiopathic hemolytic anemia and thrombocytopenia are seen, and therapy is started. Transfusion is contraindicated in thrombotic TTP, as it fuels the coagulopathy. Since the early 1990s, plasmapheresis has become the treatment of choice for TTP.
This is a shortened version of the fourth chapter of the ICD-9: Diseases of the Blood and Blood-forming Organs. It covers ICD codes 280 to 289 . The full chapter can be found on pages 167 to 175 of Volume 1, which contains all (sub)categories of the ICD-9.
Bone marrow failure, aplastic anemia, and pancytopenia. [1] Usual onset: Birth. [1] Duration: Lifelong. [1] Types: Type I and type II. [1] Causes: Genetic mutations. [2] Diagnostic method: Bone marrow biopsy and genetic testing. [3] Differential diagnosis: Thrombocytopenia-absent radius syndrome and Wiskott-Aldrich syndrome. [4] Treatment
For example, with marginally acceptable whole blood (white blood cells: < 10,000/mm³; platelets: > 150,000/mm³), a dose (3×10 11) of platelets comes with about 2×10 10 white blood cells. This can seriously damage the patient's health. A dose of single-donor platelets prepared using latest filters can contain as little as 5×10 6 white blood ...
Neonatal alloimmune thrombocytopenia (NAITP, NAIT, NATP or NAT) is a disease that affects babies in which the platelet count is decreased because the mother's immune system attacks her fetus' or newborn's platelets. A low platelet count increases the risk of bleeding in the fetus and newborn.